232 research outputs found
Identifying Outcomes and Gaps Impacting Tobacco Control and Prevention in African American Communities
Great racial disparities exist in smoking and related health outcomes in the United States. African American (AA) smokers start smoking later and smoke less than white smokers but are less likely to quit. In 2008, the CDC’s Office on Smoking and Health funded the National African American Tobacco Prevention Network (NAATPN) to focus tobacco control leadership, expertise and promotion in the AA community. In 2012, NAATPN sought to determine significant outcomes of tobacco control efforts impacting Black and AA communities by conducting a qualitative document search and series of interviews with experts in the field. Thirteen identified outcomes were categorized into five broad classifications: 1) Menthol: Emergence of menthol as a focus for advocacy, policy and research; 2) Policy and Legal: Public policy and legal action aimed at reducing tobacco usage and consumption; 3) Advocacy: Focus on national networking to facilitate growth of local, organic, and grassroots capacity in AA communities; 4) Diversity: Emergence of diversity and inclusivity as values and principles used in shaping/driving policy, advocacy, and outreach; and 5) Cessation: Creation of a cessation guide for the AA community. The identified outcomes can be used by public health practitioners in furthering their efforts to address and reduce tobacco use disparities in the AA community
Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient.
Clinical presentation of the immunoglobulin (Ig)-resistant DHTR episode in a adult patient with SC
Prosodic tools for language learning
In this paper we will be concerned with the role played by prosody in language learning and by the speech technology already available as commercial product or as prototype, capable to cope with the task of helping language learner in improving their knowledge of a second language from the prosodic point of view. The paper has been divided into two separate sections: Section One, dealing with Rhythm and all related topics; Section Two dealing with Intonation. In the Introduction we will argue that the use of ASR (Automatic Speech Recognition) as Teaching Aid should be under-utilized and should be targeted to narrowly focussed spoken exercises, disallowing open-ended dialogues, in order to ensure consistency of evaluation. Eventually, we will support the conjoined use of ASR technology and prosodic tools to produce GOP useable for linguistically consistent and adequate feedback to the student. This will be illustrated by presenting State of the Art for both sections, with systems well documented in the scientific literature of the respective field.
In order to discuss the scientific foundations of prosodic analysis we will present data related to English and Italian and make comparisons to clarify the issues at hand. In this context, we will also present the Prosodic Module of a courseware for computer-assisted foreign language learning called SLIM—an acronym for Multimedia Interactive Linguistic Software, developed at the University of Venice (Delmonte et al. in Convegno GFS-AIA, pp. 47–58, 1996a; Ed-Media 96, AACE, pp. 326–333, 1996b). The Prosodic Module has been created in order to deal with the problem of improving a student’s performance both in the perception and production of prosodic aspects of spoken language activities. It is composed of two different sets of Learning Activities, the first one dealing with phonetic and prosodic problems at word level and at syllable level; the second one dealing with prosodic aspects at phonological phrase and utterance suprasegmental level. The main goal of Prosodic Activities is to ensure consistent and pedagogically sound feedback to the student intending to improve his/her pronunciation in a foreign language
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
Background: The present study investigated the efficacy and safety of nivolumab in pre-treated patients with advanced NSCLC harbouring KRAS mutations. Methods: Clinical data and KRAS mutational status were analysed in patients treated with nivolumab within the Italian Expanded Access Program. Objective response rate, progression-free survival and overall survival were evaluated. Patients were monitored for adverse events using the National Cancer Institute Common Terminology Criteria for Adverse Events. Results: Among 530 patients evaluated for KRAS mutations, 206 (39%) were positive while 324 (61%) were KRAS wild-type mutations. KRAS status did not influence nivolumab efficacy in terms of ORR (20% vs 17%, P = 0.39) and DCR (47% vs 41%, P = 0.23). The median PFS and OS were 4 vs 3 months (P = 0.5) and 11.2 vs 10 months (P = 0.8) in the KRAS-positive vs the KRAS-negative group. The 3-months PFS rate was significantly higher in the KRAS-positive group as compared to the KRAS-negative group (53% vs 42%, P = 0.01). The percentage of any grade and grade 3–4 AEs were 45% vs 33% (P = 0.003) and 11% vs 6% (P = 0.03) in KRAS-positive and KRAS-negative groups, respectively. Conclusions: Nivolumab is an effective and safe treatment option for patients with previously treated, advanced non-squamous NSCLC regardless of KRAS mutations
Detection of ice core particles via deep neural networks
Insoluble particles in ice cores record signatures of past climate parameters like vegetation, volcanic activity or aridity. Their analytical detection depends on intensive bench microscopy investigation and requires dedicated sample preparation steps. Both are laborious, require in-depth knowledge and often restrict sampling strategies. To help overcome these limitations, we present a framework based on Flow Imaging Microscopy coupled to a deep neural network for autonomous image classification of ice core particles. We train the network to classify 7 commonly found classes: mineral dust, felsic and basaltic volcanic ash (tephra), three species of pollen (Corylus avellana, Quercus robur, Quercus suber) and contamination particles that may be introduced onto the ice core surface during core handling operations. The trained network achieves 96.8 % classification accuracy at test time. We present the system’s potentials and limitations with respect to the detection of mineral dust, pollen grains and tephra shards, using both controlled materials and real ice core samples. The methodology requires little sample material, is non destructive, fully reproducible and does not require any sample preparation step. The presented framework can bolster research in the field, by cutting down processing time, supporting human-operated microscopy and further unlocking the paleoclimate potential of ice core records by providing the opportunity to identify an array of ice core particles. Suggestions for an improved system to be deployed within a continuous flow analysis workflow are also presented
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C
The antibody profile against autoantigens previously associated with autoimmune diseases and other human proteins in patients with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) remains poorly defined. Here we show that 30% of adults with COVID-19 had autoantibodies against the lung antigen KCNRG, and 34% had antibodies to the SLE-associated Smith-D3 protein. Children with COVID-19 rarely had autoantibodies; one of 59 children had GAD65 autoantibodies associated with acute onset of insulin-dependent diabetes. While autoantibodies associated with SLE/Sjögren's syndrome (Ro52, Ro60, and La) and/or autoimmune gastritis (gastric ATPase) were detected in 74% (40/54) of MIS-C patients, further analysis of these patients and of children with Kawasaki disease (KD), showed that the administration of intravenous immunoglobulin (IVIG) was largely responsible for detection of these autoantibodies in both groups of patients. Monitoring in vivo decay of the autoantibodies in MIS-C children showed that the IVIG-derived Ro52, Ro60, and La autoantibodies declined to undetectable levels by 45-60 days, but gastric ATPase autoantibodies declined more slowly requiring >100 days until undetectable. Further testing of IgG and/or IgA antibodies against a subset of potential targets identified by published autoantigen array studies of MIS-C failed to detect autoantibodies against most (16/18) of these proteins in patients with MIS-C who had not received IVIG. However, Troponin C2 and KLHL12 autoantibodies were detected in 2 of 20 and 1 of 20 patients with MIS-C, respectively. Overall, these results suggest that IVIG therapy may be a confounding factor in autoantibody measurements in MIS-C and that antibodies against antigens associated with autoimmune diseases or other human proteins are uncommon in MIS-C
The value of trichoscopy in the differential diagnosis of scalp lesions in pemphigus vulgaris and pemphigus foliaceus
Guidance from an NIH Workshop on Designing, Implementing, and Reporting Clinical Studies of Soy Interventions1–4
The NIH sponsored a scientific workshop, “Soy Protein/Isoflavone Research: Challenges in Designing and Evaluating Intervention Studies,” July 28–29, 2009. The workshop goal was to provide guidance for the next generation of soy protein/isoflavone human research. Session topics included population exposure to soy; the variability of the human response to soy; product composition; methods, tools, and resources available to estimate exposure and protocol adherence; and analytical methods to assess soy in foods and supplements and analytes in biologic fluids and other tissues. The intent of the workshop was to address the quality of soy studies, not the efficacy or safety of soy. Prior NIH workshops and an evidence-based review questioned the quality of data from human soy studies. If clinical studies are pursued, investigators need to ensure that the experimental designs are optimal and the studies properly executed. The workshop participants identified methodological issues that may confound study results and interpretation. Scientifically sound and useful options for dealing with these issues were discussed. The resulting guidance is presented in this document with a brief rationale. The guidance is specific to soy clinical research and does not address nonsoy-related factors that should also be considered in designing and reporting clinical studies. This guidance may be used by investigators, journal editors, study sponsors, and protocol reviewers for a variety of purposes, including designing and implementing trials, reporting results, and interpreting published epidemiological and clinical studies
Recommended from our members
Noonops.
48 pages : illustrations (some color) ; 26 cm. Part of the oonopid PBI project. Cf. acknowledgments.A new genus, Noonops, is established to contain 23 species of soft-bodied, New World oonopine spiders that differ from those of Oonops Templeton and similar genera in having the male palpal bulb fused to the cymbium, and from those of Wanops Chamberlin and Ivie and Oonopoides Bryant in having shorter legs. Six specific names are transferred from Oonops to Noonops: O. floridanus (Chamberlin and Ivie) from Florida and Georgia (chosen as the type species), O. gertschi Chickering from the Bahama Islands (which is placed as a junior synonym of N. floridanus), O. furtivus Gertsch from Texas and Tamaulipas, O. sonora Gertsch and Davis from Arizona, California, Sonora, Baja California, and Baja California Sur, O. puebla Gertsch and Davis from Puebla, and O. chilapensis Chamberlin and Ivie from Guerrero. Males of N. sonora and females of N. furtivus are described for the first time; 18 new species are described: N. ocotillo, N. mortero, N. joshua, N. skinner, N. coachella, and N. californicus from Arizona and southern California and N. willisi, N. mesa, N. naci, N. tarantula, N. miraflores, N. culiacan, N. taxquillo, N. chapul, N. beattyi, N. iviei, N. tonila, and N. minutus from Mexico
- …